{
    "organizations": [],
    "uuid": "4e8151b850abc2a3374ef6879ece2c0ebf2eecd9",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-jiangsu-hengrui-medicine-unit-pass/brief-jiangsu-hengrui-medicine-unit-passes-u-s-fda-approval-idUSL4N1QK1CG",
    "ord_in_thread": 0,
    "title": "Jiangsu Hengrui Medicine unit passes U.S. FDA approval",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 2(Reuters) - Jiangsu Hengrui Medicine Co Ltd\n* Says coâ€™s unit Shanghai Hengrui Pharmaceutical Co Ltd received FDA approval for desflurane for inhalation (product) from U.S. Food and Drug Administration\n* Says unit will be able to sell the product in U.S. after receiving the FDA approval\nSource text in Chinese: goo.gl/CBkFNQ\n (Beijing Headline News)\n ",
    "published": "2018-03-02T09:33:00.000+02:00",
    "crawled": "2018-03-02T20:11:56.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "jiangsu",
        "hengrui",
        "medicine",
        "co",
        "ltd",
        "say",
        "co",
        "unit",
        "shanghai",
        "hengrui",
        "pharmaceutical",
        "co",
        "ltd",
        "received",
        "fda",
        "approval",
        "desflurane",
        "inhalation",
        "product",
        "food",
        "drug",
        "administration",
        "say",
        "unit",
        "able",
        "sell",
        "product",
        "receiving",
        "fda",
        "approval",
        "source",
        "text",
        "chinese",
        "beijing",
        "headline",
        "news"
    ]
}